Annual ROE
-74.74%
-10.52%-16.38%
31 December 2023
Summary:
NeuroBo Pharmaceuticals annual return on equity is currently -74.74%, with the most recent change of -10.52% (-16.38%) on 31 December 2023. During the last 3 years, it has risen by +29.97% (+28.62%). NRBO annual ROE is now -163.95% below its all-time high of 116.88%, reached on 31 December 2018.NRBO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-189.12%
-35.08%-22.77%
30 September 2024
Summary:
NeuroBo Pharmaceuticals quarterly return on equity is currently -189.12%, with the most recent change of -35.08% (-22.77%) on 30 September 2024. Over the past year, it has dropped by -129.70% (-218.28%). NRBO quarterly ROE is now -109.23% below its all-time high of 2048.84%, reached on 30 September 2016.NRBO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRBO ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -218.3% |
| 3 y3 years | +28.6% | -34.1% |
| 5 y5 years | +56.9% | +60.8% |
NRBO ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.4% | +28.6% | -255.6% | at low |
| 5 y | 5 years | -16.4% | +81.9% | -255.6% | +60.8% |
| alltime | all time | -163.9% | +91.2% | -109.2% | +68.6% |
NeuroBo Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -189.12%(+22.8%) |
| June 2024 | - | -154.04%(+70.7%) |
| Mar 2024 | - | -90.22%(+51.8%) |
| Dec 2023 | -74.74%(+16.4%) | -59.42%(+11.7%) |
| Sept 2023 | - | -53.18%(-12.3%) |
| June 2023 | - | -60.64%(-36.9%) |
| Mar 2023 | - | -96.06%(-16.7%) |
| Dec 2022 | -64.22%(-38.7%) | -115.31%(-14.2%) |
| Sept 2022 | - | -134.34%(-2.0%) |
| June 2022 | - | -137.09%(-2.7%) |
| Mar 2022 | - | -140.86%(-0.1%) |
| Dec 2021 | -104.71%(-74.6%) | -141.03%(-58.0%) |
| Sept 2021 | - | -336.13%(+10.9%) |
| June 2021 | - | -303.11%(+13.1%) |
| Mar 2021 | - | -267.99%(-17.0%) |
| Dec 2020 | -412.02% | -322.70%(+43.8%) |
| Sept 2020 | - | -224.41%(-26.9%) |
| June 2020 | - | -307.05%(-31.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -449.73%(-6.7%) |
| Dec 2019 | -173.38%(-248.3%) | -482.25%(-369.5%) |
| Sept 2019 | - | 178.91%(-129.7%) |
| June 2019 | - | -602.67%(+138.7%) |
| Mar 2019 | - | -252.48%(+35.9%) |
| Dec 2018 | 116.88%(-113.8%) | -185.80%(-12.0%) |
| Sept 2018 | - | -211.03%(-10.5%) |
| June 2018 | - | -235.71%(-6.8%) |
| Mar 2018 | - | -252.82%(+7.7%) |
| Dec 2017 | -847.88%(+1099.3%) | -234.83%(+27.5%) |
| Sept 2017 | - | -184.13%(+43.4%) |
| June 2017 | - | -128.37%(-8.5%) |
| Mar 2017 | - | -140.30%(-25.3%) |
| Dec 2016 | -70.70%(-196.9%) | -187.78%(-109.2%) |
| Sept 2016 | - | 2048.84%(+2188.4%) |
| June 2016 | - | 89.53%(-34.4%) |
| Mar 2016 | - | 136.47%(+87.1%) |
| Dec 2015 | 72.93%(+21.0%) | 72.93% |
| Dec 2014 | 60.26% | - |
FAQ
- What is NeuroBo Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly ROE year-on-year change?
What is NeuroBo Pharmaceuticals annual return on equity?
The current annual ROE of NRBO is -74.74%
What is the all time high annual ROE for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual return on equity is 116.88%
What is NeuroBo Pharmaceuticals quarterly return on equity?
The current quarterly ROE of NRBO is -189.12%
What is the all time high quarterly ROE for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly return on equity is 2048.84%
What is NeuroBo Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, NRBO quarterly return on equity has changed by -129.70% (-218.28%)